Responses
Clinical and epidemiological research
Extended report
Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study
Compose a Response to This Article
Other responses
No responses have been published for this article.